Quantcast

Contract Research Organization WCCT Global Announces Dynamic Solutions for Sponsors with Clinical Pharmacology Units

August 1, 2013

WCCT Global has established a dynamic process for clinical trial start up with their Clinical Pharmacology Units.

Costa Mesa, CA (PRWEB) August 01, 2013

WCCT Global, a contract research organization headquartered in Orange County, California, announced today the availability of cutting-edge solutions for sponsors looking for Clinical Pharmacology Units (CPU) with a large range of clinical research capabilities. WCCT Global owns 2 CPUs which are geographically located in densely populated areas of Southern California which makes them ideally situated for recruitment of patients and healthy volunteers. These sites offer dynamic solutions because of the different services that each CPU provides and how WCCT Global's scientific service staff can offer customized solutions based upon target therapeutic indication and population size.

The CPU in Cypress is dedicated primarily to healthy volunteer studies and has 40,000 square foot space configured to accommodate 150 beds. This location is ideally suited for long in-house duration studies such as, SAD, MAD, Asian bridging studies, BA/BE and drug-drug interaction studies. The Asian Bridging clinical study service offering is uniquely supported by the WCCT Global multi-lingual staff. WCCT Global is clearly the market leader in this category of clinical research.

The Costa Mesa, California CPU has been configured to accommodate special populations and serve as an Investigative Site for late phase clinical trials. This site has 30 beds with multiple medical procedure stations and treatment rooms strategically placed throughout the Unit.

WCCT Global is also a multi-site, full-service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, "With compassion for people, we strive for tomorrow’s therapies to be available today" truly exemplifies the focus and reason for our cutting-edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines. Mel Affrime, Sr. VP, Translational Medicine said, “It is always very exciting and satisfying for us to be able help one of our sponsors solve one of their research problems either through the unique research facilities in California or a specific patient population that we globally have access to at WCCT Global.”

If you are interested in how WCCT Global can service one of you upcoming clinical studies, CLICK HERE.

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/8/prweb10986706.htm


Source: prweb



comments powered by Disqus